1. AB0481 Demonstrated, quantifiable benefits in patient reported outcomes supporting a "treat to target" paradigm for infliximab-treated RA patients previously inadequately responsive to prior anti-TNF treatment. (23rd January 2014) Authors: Ingham, M.; Tang, L.; Decktor, D.; Bolce, R.; Wang, J. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Correlation of serum protein biomarkers with disease activity in psoriatic arthritis. (3rd March 2020) Authors: Boyd, T. A.; Eastman, P. S.; Huynh, D. H.; Qureshi, F.; Sasso, E. H.; Bolce, R.; Temple, J.; Hillman, J.; Boyle, D. L.; Kavanaugh, A. Journal: Expert review of clinical immunology Issue: Volume 16:Number 3(2020) Page Start: 335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0005 In Early RA Patients with Non-Response to Methotrexate Monotherapy the Change in Multi-Biomarker Disease Activity Score is Differentially Associated with Subsequent Response to Non-Biological versus Biological Therapy. (10th June 2014) Authors: Hambardzumyan, K.; Bolce, R.; Saevarsdottir, S.; Forslind, K.; Petersson, I.F.; Geborek, P.; Ernestam, S.; Sasso, E.H.; Chernoff, D.; Cruickshank, S.E.; Van Vollenhoven, R.F. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0060 A multi-biomarker disease activity blood test (vectra da) correlates with radiographic progression in early rheumatoid arthritis: results from the swefot trial. (23rd January 2014) Authors: Hambardzumyan, K.; Bolce, R.; Cavet, G.; Chernoff, D.; Haney, D.; Forslind, K.; Petersson, I.; Geborek, P.; Ernestam, S.; van Vollenhoven, R. F. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A388 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0061 Multi-biomarker disease activity (MBDA) score and the 12 individual biomarkers in early rheumatoid arthritis patients relate differentially to clinical response and radiographic progression: results from the swefot trial. (23rd January 2014) Authors: Hambardzumyan, K.; Saevarsdottir, S.; Bolce, R.; Forslind, K.; Ernestam, S.; Petersson, I.; Geborek, P.; Chernoff, D.; Haney, D.; Sasso, E. H.; van Vollenhoven, R. F. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A388 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FRI0066 Behavior of the multi-biomarker disease activity (vectra da algorithm) score and components in patients with rheumatoid arthritis treated with tocilizumab. (23rd January 2014) Authors: Hanami, K.; Hirata, S.; Tasaka, H.; Li, W.; Bolce, R.; Sasso, E. H.; Defranoux, N. A.; Yamaoka, K.; Saito, K.; Tanaka, Y. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A391 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0067 Changes in Multi-Biomarker Disease Activity (MBDA) Score Correlate with Changes in Established Disease Activity Measurements in Patients with Early Ra from The Opera Study. (15th July 2016) Authors: Brahe, C.H.; Østergaard, M.; Johansen, J.; Defranoux, N.; Hwang, C.-C.; Bolce, R.; Sasso, E.; Hørslev-Petersen, K.; Steengaard-Pedersen, K.; Junker, P.; Ellingsen, T.; Ahlquist, P.; Lindegaard, H.; Linauskas, A.; Schlemmer, A.; Dam, M.Y.; Hansen, I.; Lottenburger, T.; Ammitzbøll, C.; Jørgensen, A. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 450 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0277 EFFECTIVENESS OF BDMARDS IN AS AND NR-AXSPA PATIENT POPULATIONS: EXPERIENCE FROM THE CORRONA REGISTRY. (2nd June 2020) Authors: Hunter, T.; Blachley, T.; Malatestinic, W.; Harrold, L.; Dube, B.; Glynn, M.; Lisse, J.; Bolce, R.; Mease, P. J. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 725 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FRI0278 IXEKIZUMAB IMPROVES SELF-REPORTED OVERALL FUNCTIONING AND HEALTH AS MEASURED BY THE ASAS HEALTH INDEX IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS OF A PHASE 3 RANDOMIZED, ACTIVE AND PLACEBO-CONTROLLED TRIAL (COAST-X). (2nd June 2020) Authors: Kiltz, U.; Walsh, J. A.; Vargas, R. B.; Hunter, T.; Bolce, R.; Sandoval, D.; Liu Leage, S.; Leung, A.; LI, X.; Blue, E.; Braun, J. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 726 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FRI0304 Treatment of knee osteoarthritis with intra-articular infliximab improves total womac score. High baseline levels of synovial cellularity predict improvement. (23rd January 2014) Authors: Lindsley, H.B.; Schue, J.; Tawfik, O.; Bolce, R.; Smith, D.D.; Hinson, G.; Wick, J.A. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 417 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗